Shenzhen Salubris Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
Shenzhen Salubris Pharmaceuticals has a total shareholder equity of CN¥8.3B and total debt of CN¥10.0M, which brings its debt-to-equity ratio to 0.1%. Its total assets and total liabilities are CN¥9.6B and CN¥1.3B respectively. Shenzhen Salubris Pharmaceuticals's EBIT is CN¥537.3M making its interest coverage ratio -9. It has cash and short-term investments of CN¥1.8B.
Key information
0.1%
Debt to equity ratio
CN¥10.00m
Debt
| Interest coverage ratio | -9x |
| Cash | CN¥1.76b |
| Equity | CN¥8.26b |
| Total liabilities | CN¥1.35b |
| Total assets | CN¥9.61b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: 002294's short term assets (CN¥3.5B) exceed its short term liabilities (CN¥810.7M).
Long Term Liabilities: 002294's short term assets (CN¥3.5B) exceed its long term liabilities (CN¥537.1M).
Debt to Equity History and Analysis
Debt Level: 002294 has more cash than its total debt.
Reducing Debt: 002294's debt to equity ratio has reduced from 3.6% to 0.1% over the past 5 years.
Debt Coverage: 002294's debt is well covered by operating cash flow (9441.9%).
Interest Coverage: 002294 earns more interest than it pays, so coverage of interest payments is not a concern.